CF
RCEL icon

Corebridge Financial’s Avita Medical RCEL Stock Holding History

Corebridge Financial’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,732
Closed -$104K – 2153
2025
Q1 		$104K Buy
12,732
+27
+0.2% +$252 ﹤0.01% 2419
2024
Q4 		$163K Sell
12,705
-959
-7% -$11.3K ﹤0.01% 2289
2024
Q3 		$146K Sell
13,664
-84
-0.6% -$789 ﹤0.01% 2401
2024
Q2 		$109K Buy
+13,748
New +$131K ﹤0.01% 2551

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Corebridge Financial's RCEL Position: Q2 2025 in Review

Corebridge Financial sold out of Avita Medical (RCEL) in Q2 2025, closing a stake of 12,732 shares — an estimated $104K sold.

Corebridge Financial first reported a position in RCEL in Q2 2024 and held it in 4 quarters. The position peaked at $163K in Q4 2024. 80 funds tracked by Wall St. Rank hold RCEL as of Q2 2025.

  • Corebridge Financial reported no remaining Avita Medical position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 12,732 Avita Medical shares in Q2 2025, an estimated $104K.
  • Corebridge Financial first reported a position in Avita Medical in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Avita Medical position peaked at $163K in Q4 2024.
  • 80 funds tracked by Wall St. Rank held Avita Medical as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.